semaglutide liver side effects A study from the New England Journal of Medicine found new evidence that GLP-1 drugs, like Ozempic and Wegovy, used for diabetes and obesity could also help people with a type of disease. CBS Wegovy Treated Severe Liver Disease

SUSTAIN 6 demonstrated a 26% MACE reduction in T2D patients with high CV risk (basis for the CV indication in Ozempics original label)

Patients report extremely limited treatment options , a disorganized and often inaccurate website , and GLP-1 medications discontinued without notice

It's me again, still navigating this exciting but sometimes overwhelming GLP-1 journey

Obesity drugs alter eating behaviors More than half of participants said they had either a slight or large reduction in appetite with obesity therapy, including 54.4% of the Wegovy group, 62.1% of the Ozempic group and 56.5% of the Mounjaro group

In summary , while Ozempic is primarily prescribed for type 2 diabetes on the NHS, its weight loss benefits have sparked interest in its use for non-diabetic purposes

Semaglutide Administration and Dosage Semaglutide administration can be done through injections or oral tablets, each brand having specific dosages and instructions